<div class="container">

<table style="width: 100%;"><tr>
<td>fibrinogen</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2> Fibrinogen Studies Collaboration </h2>

<h3>Description</h3>

<p>The Fibrinogen Studies Collaboration is a meta-analysis of individual data on 154,012 adults from 31 prospective cohort studies with information on plasma fibrinogen and major disease outcomes. The dataset reports a subset of the results of a first-stage analysis consisting of the log-hazard ratio of coronary heart disease for categories of levels of fibrinogen versus a baseline category.
</p>


<h3>Usage</h3>

<pre><code class="language-R">fibrinogen</code></pre>


<h3>Format</h3>

<p>A data frame with 31 observations on the following 15 variables:
</p>

<ul>
<li>
<p><code>cohort</code>: study ID.
</p>
</li>
<li>
<p><code>b2, b3, b4, b5</code>: estimated log-hazard ratios for the second to fifth categories versus the baseline category.
</p>
</li>
<li>
<p><code>V_2_2, V_3_3, V_4_4, V_5_5</code>: variances of the estimated log-hazard ratios.
</p>
</li>
<li>
<p><code>V_2_3, V_2_4, V_2_5, V_3_4, V_3_5, V_4_5</code>: covariances of the estimated log-hazard ratios.
</p>
</li>
</ul>
<h3>Details</h3>

<p>The published analysis adopted a fixed-effects model on 10 categories of fibrinogen (Fibrinogen Studies Collaboration 2004, 2005). Here a subset of the results of the first-stage analysis is reported, namely the log-hazard ratio for 4 categories and associated (co)variance terms, ordered as the lower triangular elements of the (co)variance matrix taken by column. Details on the first-stage model and the second-stage meta-analysis are provided in White (2009) and Jackson and colleagues (2010).
</p>


<h3>Note</h3>

<p>The data provide an example of application of multivariate meta-analysis for multi-parameter association, where a relationship is defined by functions specified by several coefficients. In this case, the coefficients refer to log-hazard ratio for strata of the original variable versus a baseline category. A general overview of the application of multivariate meta-analysis in this setting is provided by Gasparrini and colleagues (2012).
</p>


<h3>Source</h3>

<p>Fibrinogen Studies Collaboration (2004). Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease. <em>European Journal of Cardiovascular Prevention and Rehabilitation</em>. <b>11</b>:9–17.
</p>
<p>Fibrinogen Studies Collaboration (2005). Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. <em>Journal of the American Medical Association</em>. <b>294</b>:1799–1809.
</p>
<p>White IR (2009). Multivariate random-effects meta-analysis. <em>Stata Journal</em>. <b>9</b>(1):40–56.
</p>
<p>Jackson D, White IR, Thompson SG (2010). Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. <em>Statistics in Medicine</em>. <b>29</b>(12):1282–1297.
</p>
<p>Sera F, Armstrong B, Blangiardo M, Gasparrini A (2019). An extended mixed-effects framework for meta-analysis.<em>Statistics in Medicine</em>. 2019;38(29):5429-5444. [Freely available <a href="http://www.ag-myresearch.com/2019_sera_statmed.html"><b>here</b></a>].
</p>


<h3>Examples</h3>

<pre><code class="language-R">### REPRODUCE THE RESULTS IN WHITE (2009) AND JACKSON ET AL. (2010)

# INSPECT THE DATA
head(fibrinogen)

# REML MODEL
y &lt;- as.matrix(fibrinogen[2:5])
S &lt;- as.matrix(fibrinogen[6:15])
model &lt;- mixmeta(y, S)

# SUMMARIZE THE RESULTS
print(summary(model), digits=3)
round(model$Psi, 3)
</code></pre>


</div>